Distributed

No. 18-127

Amgen Inc., et al. v. Sanofi, et al.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

DISTRIBUTED for Conference of 1/4/2019.

Reply of petitioners Amgen Inc., et al. filed. (Distributed)

Brief of respondents Sanofi, et al. in opposition filed.

DISTRIBUTED for Conference of 10/5/2018.

Brief amici curiae of Bristol-Myers Squibb Company, Morphosys AG, Bavarian Nordic A/S, and UCB Biopharma SPRL filed.

Petition for a writ of certiorari filed. (Response due August 27, 2018)

Application (17A1262) granted by The Chief Justice extending the time to file until July 23, 2018.

Application (17A1262) to extend the time to file a petition for a writ of certiorari from May 24, 2018 to July 23, 2018, submitted to The Chief Justice.

Parties

Amgen Inc., et al., Petitioner, represented by Jeffrey Alan Lamken

Amici Curiae

Bristol-Myers Squibb Company, Morphosys AG, Bavarian Nordic A/S, and UCB Biopharma SPRL, Amicus Curiae, represented by Jorge Alberto Goldstein

 
Last updated: December 13, 2018